Discover
TTRX
Turn Therapeutics Inc.
12.00
1 x 7.65
1 x 7.37
bid
ask
+
0.61
5.36%
1 @ 04:00 PM
12.00 +0.00 (0.00%)
| Ytd | 204.57% | |
| 1y | 30.43% |
11.30
day range
12.00
2.71
52 week range
15.34
| Open | 11.34 | Prev Close | 11.39 | Low | 11.30 | High | 12.00 | Mkt Cap | 364.41M |
| Vol | 109.83K | Avg Vol | 110.43K | EPS | -0.29 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 11.35 | 200-d Avg | 6.46 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.63M | ||
| Research and Development Expense | 475.06K | ||
| Selling, General and Administrative Expense | 1.15M | ||
| Operating Income | -1.63M | ||
| Interest Expense | 241.36K | ||
| Net Income | -5.85M | ||
| Net Income Common Stock | -5.85M | ||
| Net Income Common Stock (USD) | -5.85M | ||
| Consolidated Income | -5.85M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -5.61M | ||
| Earning Before Interest & Taxes (USD) | -5.61M | ||
| Weighted Average Shares | 29.79M | ||
| Weighted Average Shares Diluted | 29.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.29M | ||
| Cash and Equivalents (USD) | 10.29M | ||
| Current Assets | 10.43M | ||
| Property, Plant & Equipment Net | 56.28K | ||
| Total Assets | 16.96M | ||
| Debt Current | 49.33K | ||
| Total Debt | 6.12M | ||
| Current Liabilities | 8.76M | ||
| Debt Non-Current | 6.07M | ||
| Total Liabilities | 16.27M | ||
| Accumulated Retained Earnings (Deficit) | -29.21M | ||
| Shareholders Equity | 686.89K | ||
| Shareholders Equity (USD) | 686.89K | ||
| Assets Non-Current | 6.53M | ||
| Total Debt (USD) | 6.12M | ||
| Deferred Revenue | 1.44M | ||
| Goodwill and Intangible Assets | 911.22K | ||
| Liabilities Non-Current | 7.51M | ||
| Trade and Non-Trade Payables | 2.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.53K | ||
| Net Cash Flow from Financing | 1.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -929.16K | ||
| Issuance (Repayment) of Debt Securities | 1.00 | ||
| Net Cash Flow from Investing | -5.80K | ||
| Net Cash Flow from Operations | -923.36K | ||
| Share Based Compensation | 419.23K | ||